Evergreen Therapy Center Llc - Medicare Mental Health Clinic in Coralville, IA

Evergreen Therapy Center Llc is a medicare enrolled mental health clinic (Clinic/center - Mental Health (including Community Mental Health Center)) in Coralville, Iowa. The current practice location for Evergreen Therapy Center Llc is 2140 Norcor Ave Ste 103, Coralville, Iowa. For appointments, you can reach them via phone at (319) 853-8762. The mailing address for Evergreen Therapy Center Llc is 144 Lockmoor Cir, North Liberty, Iowa and phone number is (319) 853-8762.

Evergreen Therapy Center Llc is licensed to practice in * (Not Available) (license number ). The clinic also participates in the medicare program and its NPI number is 1043828825. This medical practice accepts medicare insurance (which means this clinic accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance). However, please confirm if they accept your insurance at (319) 853-8762.

Contact Information

Evergreen Therapy Center Llc
2140 Norcor Ave Ste 103
Coralville
IA 52241-9736
(319) 853-8762
Not Available

Mental Health Clinic Profile

Full NameEvergreen Therapy Center Llc
SpecialityClinic/Center
Location2140 Norcor Ave Ste 103, Coralville, Iowa
Authorized Official Name and PositionJason Drwal (OWNER)
Authorized Official Contact3198538762
Accepts Medicare InsuranceYes. This clinic participates in medicare program and accept medicare insurance.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Evergreen Therapy Center Llc
144 Lockmoor Cir
North Liberty
IA 52317-8042

Ph: (319) 853-8762
Evergreen Therapy Center Llc
2140 Norcor Ave Ste 103
Coralville
IA 52241-9736

Ph: (319) 853-8762

NPI Details:

NPI Number1043828825
Provider Enumeration Date07/17/2020
Last Update Date07/17/2020
Certification Date07/17/2020

Medicare PECOS Information:

Medicare PECOS PAC ID8527465863
Medicare Enrollment IDO20210929000624

News Archive

DDW2010 Investor Event to provide update on TARGET 1 and TARGET 2 Phase 3 trials

Salix Pharmaceuticals, Ltd. today announced that the Company will host a DDW2010 Investor Event on Monday, May 3 2010 from 9:00 p.m. to 10:00 p.m. Central Time (10:00 p.m. to 11:00 p.m. ET).

Hyperactive children three times more likely to be removed from their families

Severely hyperactive children are three times more likely to be removed from their families, because their parents can no longer cope, than children with other mental health or behavioural problems, reveals research in Archives of Disease in Childhood.

Researchers identify genetic mutation that may cause parkinsonism in young people

Researchers at the University of Copenhagen and the Copenhagen University Hospital have identified a particular genetic mutation that may cause parkinsonism in young people. The mutation interferes with the brain's transport of the important signal substance dopamine and may also plays a role in mental diseases, e.g. ADHD.

Functional link between IKBKE and Akt activation in breast cancer

Publishing in the current issue of The Journal of Biological Chemistry (Vol. 286, No 43), researchers at Moffitt Cancer Center in Tampa, Fla., have discovered additional mechanisms of "Akt" activation and suggest a component of that activation mechanism - inhibitor of nuclear factor kappa-B kinase subunit epsilon (IKBKE) - could be targeted as a therapeutic intervention for treating cancer.

Read more Medical News

› Verified 9 days ago

Medical Identifiers

Medical identifiers for Evergreen Therapy Center Llc such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1043828825NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
261QM0801XClinic/center - Mental Health (including Community Mental Health Center) (* (Not Available))Primary
261QM0850XClinic/center - Adult Mental Health (* (Not Available))Secondary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Evergreen Therapy Center Llc acts as a billing entity for following providers:
Provider NameLarry M Newman
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1093141129
PECOS PAC ID: 9436387354
Enrollment ID: I20140122000585

News Archive

DDW2010 Investor Event to provide update on TARGET 1 and TARGET 2 Phase 3 trials

Salix Pharmaceuticals, Ltd. today announced that the Company will host a DDW2010 Investor Event on Monday, May 3 2010 from 9:00 p.m. to 10:00 p.m. Central Time (10:00 p.m. to 11:00 p.m. ET).

Hyperactive children three times more likely to be removed from their families

Severely hyperactive children are three times more likely to be removed from their families, because their parents can no longer cope, than children with other mental health or behavioural problems, reveals research in Archives of Disease in Childhood.

Researchers identify genetic mutation that may cause parkinsonism in young people

Researchers at the University of Copenhagen and the Copenhagen University Hospital have identified a particular genetic mutation that may cause parkinsonism in young people. The mutation interferes with the brain's transport of the important signal substance dopamine and may also plays a role in mental diseases, e.g. ADHD.

Functional link between IKBKE and Akt activation in breast cancer

Publishing in the current issue of The Journal of Biological Chemistry (Vol. 286, No 43), researchers at Moffitt Cancer Center in Tampa, Fla., have discovered additional mechanisms of "Akt" activation and suggest a component of that activation mechanism - inhibitor of nuclear factor kappa-B kinase subunit epsilon (IKBKE) - could be targeted as a therapeutic intervention for treating cancer.

Read more Medical News

› Verified 9 days ago

Provider NameNatalie A Quinn
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1982111761
PECOS PAC ID: 7810311305
Enrollment ID: I20200716001915

News Archive

DDW2010 Investor Event to provide update on TARGET 1 and TARGET 2 Phase 3 trials

Salix Pharmaceuticals, Ltd. today announced that the Company will host a DDW2010 Investor Event on Monday, May 3 2010 from 9:00 p.m. to 10:00 p.m. Central Time (10:00 p.m. to 11:00 p.m. ET).

Hyperactive children three times more likely to be removed from their families

Severely hyperactive children are three times more likely to be removed from their families, because their parents can no longer cope, than children with other mental health or behavioural problems, reveals research in Archives of Disease in Childhood.

Researchers identify genetic mutation that may cause parkinsonism in young people

Researchers at the University of Copenhagen and the Copenhagen University Hospital have identified a particular genetic mutation that may cause parkinsonism in young people. The mutation interferes with the brain's transport of the important signal substance dopamine and may also plays a role in mental diseases, e.g. ADHD.

Functional link between IKBKE and Akt activation in breast cancer

Publishing in the current issue of The Journal of Biological Chemistry (Vol. 286, No 43), researchers at Moffitt Cancer Center in Tampa, Fla., have discovered additional mechanisms of "Akt" activation and suggest a component of that activation mechanism - inhibitor of nuclear factor kappa-B kinase subunit epsilon (IKBKE) - could be targeted as a therapeutic intervention for treating cancer.

Read more Medical News

› Verified 9 days ago

Provider NameJason Matthew Drwal
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1164669594
PECOS PAC ID: 9436556776
Enrollment ID: I20210929000717

News Archive

DDW2010 Investor Event to provide update on TARGET 1 and TARGET 2 Phase 3 trials

Salix Pharmaceuticals, Ltd. today announced that the Company will host a DDW2010 Investor Event on Monday, May 3 2010 from 9:00 p.m. to 10:00 p.m. Central Time (10:00 p.m. to 11:00 p.m. ET).

Hyperactive children three times more likely to be removed from their families

Severely hyperactive children are three times more likely to be removed from their families, because their parents can no longer cope, than children with other mental health or behavioural problems, reveals research in Archives of Disease in Childhood.

Researchers identify genetic mutation that may cause parkinsonism in young people

Researchers at the University of Copenhagen and the Copenhagen University Hospital have identified a particular genetic mutation that may cause parkinsonism in young people. The mutation interferes with the brain's transport of the important signal substance dopamine and may also plays a role in mental diseases, e.g. ADHD.

Functional link between IKBKE and Akt activation in breast cancer

Publishing in the current issue of The Journal of Biological Chemistry (Vol. 286, No 43), researchers at Moffitt Cancer Center in Tampa, Fla., have discovered additional mechanisms of "Akt" activation and suggest a component of that activation mechanism - inhibitor of nuclear factor kappa-B kinase subunit epsilon (IKBKE) - could be targeted as a therapeutic intervention for treating cancer.

Read more Medical News

› Verified 9 days ago

Provider NameJulie Easton Peterson
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1619516960
PECOS PAC ID: 0749610020
Enrollment ID: I20220707003103

News Archive

DDW2010 Investor Event to provide update on TARGET 1 and TARGET 2 Phase 3 trials

Salix Pharmaceuticals, Ltd. today announced that the Company will host a DDW2010 Investor Event on Monday, May 3 2010 from 9:00 p.m. to 10:00 p.m. Central Time (10:00 p.m. to 11:00 p.m. ET).

Hyperactive children three times more likely to be removed from their families

Severely hyperactive children are three times more likely to be removed from their families, because their parents can no longer cope, than children with other mental health or behavioural problems, reveals research in Archives of Disease in Childhood.

Researchers identify genetic mutation that may cause parkinsonism in young people

Researchers at the University of Copenhagen and the Copenhagen University Hospital have identified a particular genetic mutation that may cause parkinsonism in young people. The mutation interferes with the brain's transport of the important signal substance dopamine and may also plays a role in mental diseases, e.g. ADHD.

Functional link between IKBKE and Akt activation in breast cancer

Publishing in the current issue of The Journal of Biological Chemistry (Vol. 286, No 43), researchers at Moffitt Cancer Center in Tampa, Fla., have discovered additional mechanisms of "Akt" activation and suggest a component of that activation mechanism - inhibitor of nuclear factor kappa-B kinase subunit epsilon (IKBKE) - could be targeted as a therapeutic intervention for treating cancer.

Read more Medical News

› Verified 9 days ago

Provider NameJaci Rolffs
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1497274260
PECOS PAC ID: 7517300395
Enrollment ID: I20240208002298

News Archive

DDW2010 Investor Event to provide update on TARGET 1 and TARGET 2 Phase 3 trials

Salix Pharmaceuticals, Ltd. today announced that the Company will host a DDW2010 Investor Event on Monday, May 3 2010 from 9:00 p.m. to 10:00 p.m. Central Time (10:00 p.m. to 11:00 p.m. ET).

Hyperactive children three times more likely to be removed from their families

Severely hyperactive children are three times more likely to be removed from their families, because their parents can no longer cope, than children with other mental health or behavioural problems, reveals research in Archives of Disease in Childhood.

Researchers identify genetic mutation that may cause parkinsonism in young people

Researchers at the University of Copenhagen and the Copenhagen University Hospital have identified a particular genetic mutation that may cause parkinsonism in young people. The mutation interferes with the brain's transport of the important signal substance dopamine and may also plays a role in mental diseases, e.g. ADHD.

Functional link between IKBKE and Akt activation in breast cancer

Publishing in the current issue of The Journal of Biological Chemistry (Vol. 286, No 43), researchers at Moffitt Cancer Center in Tampa, Fla., have discovered additional mechanisms of "Akt" activation and suggest a component of that activation mechanism - inhibitor of nuclear factor kappa-B kinase subunit epsilon (IKBKE) - could be targeted as a therapeutic intervention for treating cancer.

Read more Medical News

› Verified 9 days ago

News Archive

DDW2010 Investor Event to provide update on TARGET 1 and TARGET 2 Phase 3 trials

Salix Pharmaceuticals, Ltd. today announced that the Company will host a DDW2010 Investor Event on Monday, May 3 2010 from 9:00 p.m. to 10:00 p.m. Central Time (10:00 p.m. to 11:00 p.m. ET).

Hyperactive children three times more likely to be removed from their families

Severely hyperactive children are three times more likely to be removed from their families, because their parents can no longer cope, than children with other mental health or behavioural problems, reveals research in Archives of Disease in Childhood.

Researchers identify genetic mutation that may cause parkinsonism in young people

Researchers at the University of Copenhagen and the Copenhagen University Hospital have identified a particular genetic mutation that may cause parkinsonism in young people. The mutation interferes with the brain's transport of the important signal substance dopamine and may also plays a role in mental diseases, e.g. ADHD.

Functional link between IKBKE and Akt activation in breast cancer

Publishing in the current issue of The Journal of Biological Chemistry (Vol. 286, No 43), researchers at Moffitt Cancer Center in Tampa, Fla., have discovered additional mechanisms of "Akt" activation and suggest a component of that activation mechanism - inhibitor of nuclear factor kappa-B kinase subunit epsilon (IKBKE) - could be targeted as a therapeutic intervention for treating cancer.

Read more News

› Verified 9 days ago

Clinic/Center in Coralville, IA

Anne M. Green
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 2000 James St, Suite 211, Coralville, IA 52241
Phone: 319-358-9397    
New Leaf Counseling, Pllc
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 1303 5th St Ste 202, Coralville, IA 52241
Phone: 319-321-5707    Fax: 866-468-4419
Ancera Psychology Associates Pc
Mental Health Clinic
Medicare: Medicare Enrolled
Practice Location: 1101 5th St, Suite 102, Coralville, IA 52241
Phone: 319-351-9777    
The Hauser Clinic
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 2570 Holiday Rd, Suite 150, Coralville, IA 52241
Phone: 319-338-2922    Fax: 319-337-2795
Susan G Schmitz, Lisw, Inc
Mental Health Clinic
Medicare: Medicare Enrolled
Practice Location: 1150 5th St Ste 261, Coralville, IA 52241
Phone: 319-354-0786    
Renaissance Remedial Services, Inc
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 806 5th St Ste 210, Coralville, IA 52241
Phone: 319-594-8686    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.